Longitudinal Quantitative <scp>MRI</scp> Provides Responsive Outcome Measures for Early and Late Muscle Changes in <scp>ALS</scp>
High responsiveness and low variability make quantitative muscle MRI a novel and complementary outcome measure for ALS clinical trials.
Authors
- Catherine Bresee (ORCID: https://orcid.org/0000-0002-5710-4906)
- Pablo Avalos (ORCID: https://orcid.org/0000-0002-5313-5334)
- John S. Thornton (ORCID: https://orcid.org/0000-0003-3248-8437)
- Frank Diaz (ORCID: https://orcid.org/0000-0003-3526-1852)
- Jasper M. Morrow (ORCID: https://orcid.org/0000-0001-6879-8539)
- Stephen Wastling (ORCID: https://orcid.org/0000-0003-4648-9932)
- Clive N. Svendsen (ORCID: https://orcid.org/0000-0001-8696-3446)
- Pamela J. Shaw (ORCID: https://orcid.org/0000-0002-8925-2567)
- Richard A. Lewis (ORCID: https://orcid.org/0000-0002-1140-4575)
- Peggy Allred
- Nick Zafeiropoulos
- Abeer Asaab
Institutions
- Cedars-Sinai Medical Center (US)
- Novartis (United States) (US)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
Publication Details
- Journal
- Muscle & Nerve
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1002/mus.28306
- Citations
- 3
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.11